All
1.
Age-dependent changes in the expression of regulatory cell surface ligands in activated human T-cells
David H Canaday, Karen E Parker, Htin Aung, Hui Emily Chen, Dariana Nunez-Medina, Christopher J Burant BMC Immunology 2013, 14 :45 (1 October 2013)
Abstract | Provisional PDF
2.
Prothymosin alpha and a prothymosin alpha-derived peptide enhance TH1-type immune responses against defined HER-2/neu epitopes
Kyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, Pinelopi Samara, Hubert Kalbacher, Wolfgang Voelter, Ioannis P Trougakos, Graham Pawelec, Ourania E Tsitsilonis BMC Immunology 2013, 14 :43 (22 September 2013)
Abstract | Provisional PDF
| PubMed
3.
Quantification of total T-cell receptor diversity by flow cytometry and spectratyping
Stanca M Ciupe, Blythe H Devlin, Mary Markert, Thomas B Kepler BMC Immunology 2013, 14 :35 (6 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
4.
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Jennifer Pieper, Jessica Herrath, Sukanya Raghavan, Khalid Muhammad, Ronald van Vollenhoven, Vivianne Malmström BMC Immunology 2013, 14 :34 (5 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
Editor’s summary
Immunological study of T cell functionality in rheumatoid arthritis patients, both ACPA-positive and ACPA-negative, starting biological therapy with the co-stimulation blockade abatacept (CTLA4-Ig), supports the recently published registry study implicating ACPA seropositivity as an independent predictive factor to treatment response.
5.
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T Cells
Jon G Quatromoni, Eiji Suzuki, Olugbenga Okusanya, Brendan F Judy, Pratik Bhojnagarwala, Ollin Venegas, Evgeniy Eruslanov, Jarrod D Predina, Steven M Albelda, Sunil Singhal BMC Immunology 2013, 14 :30 (17 July 2013)
Abstract | Full text | PDF
| PubMed
6.
Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort
Damalie Nakanjako, Isaac Ssewanyana, Rose Nabatanzi, Agnes Kiragga, Moses R Kamya, Huyen Cao, Harriet Mayanja-Kizza BMC Immunology 2013, 14 :26 (20 June 2013)
Abstract | Full text | PDF
| ePUB | PubMed
7.
Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase
Haiyun Dong, Jinxiu Li, Youdi Lv, Yanyan Zhou, Guyi Wang, Shuang Hu, Xiaoyu He, Ping Yang, Zhiguang Zhou, Xudong Xiang, Cong-Yi Wang BMC Immunology 2013, 14 :25 (17 June 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation
Zichen Li, Ke Li, Lin Zhu, Quancheng Kan, Yaping Yan, Priyanka Kumar, Hui Xu, Abdolmohamad Rostami, Guang-Xian Zhang BMC Immunology 2013, 14 :20 (23 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
|
Editor’s summary
Mouse neural stem cells express Interleukin-17 (IL-17) receptors and treatment with IL-17 reduces neurosphere formation, cell number, proliferation and differentiation suggesting they may play a role in inducing demyelination and blocking neuronal repair in autoimmune disease.
9.
BATF regulates the development and function of IL-17 producing iNKT cells
Kimberly L Jordan-Williams, Stacie Poston, Elizabeth J Taparowsky BMC Immunology 2013, 14 :16 (27 March 2013)
Abstract | Full text | PDF
| PubMed
10.
Characterization of murine macrophages from bone marrow, spleen and peritoneum
Changqi Wang, Xiao Yu, Qi Cao, Ya Wang, Guoping Zheng, Thian Kui Tan, Hong Zhao, Ye Zhao, Yiping Wang, David CH Harris BMC Immunology 2013, 14 :6 (5 February 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
A comparison study of mouse macrophages derived from spleen, bone marrow and peritoneum demonstrates their distinct characteristics which may be relevant to their respective roles in the immune response.
